Insight Partners has sold CentralReach to Roper Technologies for around $1.65 billion, according to a news release.

CentralReach, founded in 2012 and based in Fort Lauderdale, Florida, is a provider of software to support the workflow and administration of applied behavior analysis therapy.

Insight Partners, founded in 1995 and based in New

On March 7, 2025, the California Privacy Protection Agency (“CPPA”), which is tasked with enforcing the California Consumer Privacy Act (“CCPA”) entered a Stipulated Final Order (“Order”) with American Honda Motor Co., Inc. (“Honda”), fining Honda $632,500.  This Order is instructive as to CPPA’s views on various topics covered by the CCPA.  Among other things, the Order makes clear that:

The guidance U.S. companies have been waiting for after years of ups and downs is finally here.  In line with our last update, on March 21, 2025, FinCEN issued an interim final rule exempting U.S. companies and persons from the requirement to report, modify, or correct beneficial ownership information under the Corporate Transparency Act (CTA) by excluding such entities from the scope of the term “reporting company.” 

Knox Lane has announced an investment in Healthcare Experts Squared (HCEsquared).

HCEsquared, founded in 2001 and based in Vail, Colorado, is an education, information and services platform serving healthcare professionals.

Knox Lane, founded in 2019 and based in San Francisco, is a middle market investment firm targeting companies within the consumer and services

McGuireWoods partner and host Geoff Cockrell invites Jeremy Johnson, senior managing director at Bourne Partners investment bank, for a discussion about business and investment prospects in three healthcare sectors: pharma services, provider services and payor services. 

The pharma services sector faces challenges from reduced biopharma funding while the provider services sector sees improving conditions

InTandem Capital Partners has announced it has completed an investment in Clinilabs.

Clinilabs, founded in 2000 and based in Eatontown, New Jersey, is a contract research organization focused on central nervous system drug, device and technology development.

InTandem, founded in 2011 and based in New York, focuses on acquiring middle market healthcare services